Total Payments
$1,074
2024 Payments
$62.48
Companies
19
Transactions
33
Medicare Patients
7,970
Medicare Billing
$574,141
Payment Breakdown by Category
Food & Beverage$1,074 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,074 | 33 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $364.30 | 5 | $0 (2019) |
| Teleflex LLC | $143.67 | 1 | $0 (2023) |
| Axonics, Inc. | $141.46 | 1 | $0 (2022) |
| Antares Pharma, Inc. | $92.17 | 5 | $0 (2021) |
| Dendreon Pharmaceuticals LLC | $51.61 | 3 | $0 (2019) |
| Bayer Healthcare Pharmaceuticals Inc. | $36.57 | 2 | $0 (2023) |
| Tolmar, Inc. | $31.46 | 2 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $29.86 | 2 | $0 (2020) |
| Amgen Inc. | $28.79 | 2 | $0 (2020) |
| GENZYME CORPORATION | $17.49 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $62.48 | 4 | Tolmar, Inc. ($31.46) |
| 2023 | $182.21 | 3 | Teleflex LLC ($143.67) |
| 2022 | $156.87 | 2 | Axonics, Inc. ($141.46) |
| 2021 | $168.97 | 10 | Antares Pharma, Inc. ($77.89) |
| 2020 | $57.94 | 4 | Amgen Inc. ($28.79) |
| 2019 | $116.34 | 3 | Boston Scientific Corporation ($87.01) |
| 2018 | $119.88 | 4 | BOSTON SCIENTIFIC CORPORATION ($90.74) |
| 2017 | $209.68 | 3 | BOSTON SCIENTIFIC CORPORATION ($186.55) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 2 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/05/2019 | Endo Pharmaceuticals Inc. | EDEX (Drug), XIAFLEX, AVEED | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: UROLOGY | ||||||
| 12/12/2018 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $15.00 | General |
| Category: Oncology | ||||||
| 10/19/2018 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 03/15/2018 | BOSTON SCIENTIFIC CORPORATION | GENERAL ERECTILE DYSFUNCTION (Device) | Food and Beverage | In-kind items and services | $41.16 | General |
| Category: ERECTILE DYSFUNCTION | ||||||
| 01/30/2018 | BOSTON SCIENTIFIC CORPORATION | AMS (Device) | Food and Beverage | In-kind items and services | $49.58 | General |
| Category: ERECTILE DYSFUNCTION | ||||||
| 10/10/2017 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 07/06/2017 | BOSTON SCIENTIFIC CORPORATION | GENERAL - KIDNEY STONE DISEASE (Device) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: KIDNEY STONE DISEASE | ||||||
| 06/22/2017 | BOSTON SCIENTIFIC CORPORATION | LITHOVUE (Device) | Food and Beverage | In-kind items and services | $166.97 | General |
| Category: SCOPE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 2,680 | 4,034 | $729,185 | $193,373 |
| 2022 | 27 | 2,058 | 3,191 | $556,808 | $154,448 |
| 2021 | 21 | 1,705 | 2,592 | $559,900 | $120,464 |
| 2020 | 23 | 1,527 | 2,193 | $512,795 | $105,857 |
Total Patients
7,970
Total Services
12,010
Medicare Billing
$574,141
Procedure Codes
99
All Medicare Procedures & Services
99 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 409 | 692 | $190,160 | $70,463 | 37.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 263 | 360 | $67,680 | $28,096 | 41.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 128 | 128 | $52,736 | $17,053 | 32.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 54 | 59 | $52,510 | $12,856 | 24.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 60 | 63 | $31,311 | $9,268 | 29.6% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2023 | 13 | 13 | $53,170 | $7,537 | 14.2% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 88 | 107 | $21,507 | $5,587 | 26.0% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 50 | 80 | $28,000 | $5,464 | 19.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 66 | 104 | $10,088 | $4,356 | 43.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 246 | 378 | $43,470 | $3,622 | 8.3% |
| 76857 | Limited ultrasound scan of pelvis | Office | 2023 | 76 | 89 | $14,952 | $3,592 | 24.0% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 116 | 176 | $13,376 | $3,172 | 23.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 472 | 902 | $9,922 | $3,050 | 30.7% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 21 | 23 | $57,500 | $2,784 | 4.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 20 | 50 | $5,800 | $2,380 | 41.0% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 22 | 24 | $9,336 | $2,351 | 25.2% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 22 | 22 | $9,504 | $2,255 | 23.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 132 | 197 | $2,955 | $1,655 | 56.0% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 14 | 14 | $20,202 | $1,551 | 7.7% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 14 | 25 | $10,625 | $1,354 | 12.7% |
| 87088 | Bacterial urine culture | Office | 2023 | 100 | 137 | $4,658 | $1,078 | 23.2% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 100 | 138 | $4,554 | $1,076 | 23.6% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 29 | 38 | $2,242 | $796.86 | 35.5% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2023 | 59 | 82 | $1,066 | $678.38 | 63.6% |
| 87077 | Bacterial culture for aerobic isolates | Office | 2023 | 55 | 76 | $2,508 | $586.08 | 23.4% |
About Dr. Alon Mass, M.D
Dr. Alon Mass, M.D is a Urology healthcare provider based in Cranford, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/30/2012. The National Provider Identifier (NPI) number assigned to this provider is 1447511191.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alon Mass, M.D has received a total of $1,074 in payments from pharmaceutical and medical device companies, with $62.48 received in 2024. These payments were reported across 33 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,074).
As a Medicare-enrolled provider, Mass has provided services to 7,970 Medicare beneficiaries, totaling 12,010 services with total Medicare billing of $574,141. Data is available for 4 years (2020–2023), covering 99 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Cranford, NJ
- Active Since 05/30/2012
- Last Updated 07/21/2022
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1447511191
Products in Payments
- LITHOVUE (Device) $166.97
- UROLIFT (Device) $143.67
- Axonics (Device) $141.46
- GENERAL ERECTILE DYSFUNCTION (Device) $87.01
- XYOSTED (Drug) $77.89
- PROVENGE (Drug) $51.61
- AMS (Device) $49.58
- GENERAL ERECTILE DYSFUNCTION (Device) $41.16
- ELIGARD (Drug) $31.46
- Prolia (Biological) $28.79
- GEMTESA (Drug) $28.13
- Nubeqa (Drug) $21.73
- GENERAL - KIDNEY STONE DISEASE (Device) $19.58
- JELMYTO (Drug) $16.81
- AVEED (Biological) $16.48
- Prolaris (Device) $15.67
- A4 and Epm monitors (Device) $15.41
- Lenvima (Drug) $15.00
- EDEX (Drug) $14.99
- CEREC (Device) $14.89
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Cranford
Neil Sherman, M.d, M.D
Urology — Payments: $8,807
Urology $8,807
Dr. Kenneth Ring, M.d, M.D
Urology — Payments: $5,925
Urology $5,925
Dr. Zein Nakhoda, M.d, M.D
Urology — Payments: $5,722
Urology $5,722
Dr. Michael Lasser, M.d, M.D
Urology — Payments: $3,599
Urology $3,599
Dr. Andrew Bernstein, M.d, M.D
Urology — Payments: $2,150
Urology $2,150
Jamie Uy, M.d, M.D
Urology — Payments: $200.17
Urology $200.17